We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$1.03B 6.62%
2,459,888
+45,025
+2% +$18.2M
AAPL icon
2
Apple
AAPL
$4.79T
$647M 4.14%
3,774,731
+291,542
+8% +$53M
NVDA icon
3
NVIDIA
NVDA
$5.14T
$620M 3.96%
6,857,790
+886,690
+15% +$64.3M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.17T
$461M 2.95%
3,055,714
-187,158
-6% -$26.8M
MRK icon
5
Merck
MRK
$315B
$326M 2.09%
2,473,330
-556,959
-18% -$68.6M
LLY icon
6
Eli Lilly
LLY
$1.04T
$319M 2.04%
410,537
+33,025
+9% +$23.5M
TMO icon
7
Thermo Fisher Scientific
TMO
$196B
$248M 1.59%
427,087
-68,180
-14% -$38.3M
AMZN icon
8
Amazon
AMZN
$2.63T
$225M 1.44%
1,247,724
+164,351
+15% +$27.4M
V icon
9
Visa
V
$672B
$221M 1.41%
791,804
+21,841
+3% +$6.03M
REGN icon
10
Regeneron Pharmaceuticals
REGN
$68.3B
$210M 1.34%
217,771
-23,847
-10% -$22.7M
AMGN icon
11
Amgen
AMGN
$198B
$196M 1.25%
688,360
-71,061
-9% -$20.8M
UNH icon
12
UnitedHealth
UNH
$392B
$194M 1.24%
392,352
-48,196
-11% -$24.5M
MA icon
13
Mastercard
MA
$470B
$190M 1.21%
393,713
+28,418
+8% +$13M
CRM icon
14
Salesforce
CRM
$133B
$181M 1.16%
600,371
+183,051
+44% +$52.8M
PG icon
15
Procter & Gamble
PG
$347B
$171M 1.1%
1,055,507
+19,557
+2% +$3.07M
GILD icon
16
Gilead Sciences
GILD
$162B
$167M 1.07%
2,285,129
+44,892
+2% +$3.45M
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$120B
$162M 1.04%
388,588
+46,502
+14% +$19.7M
AMD icon
18
Advanced Micro Devices
AMD
$901B
$146M 0.93%
809,399
-111,164
-12% -$19.4M
GOOG icon
19
Alphabet (Google) Class C
GOOG
$4.17T
$145M 0.93%
950,929
-17,298
-2% -$2.5M
WM icon
20
Waste Management
WM
$94.9B
$136M 0.87%
639,796
-16,989
-3% -$3.34M
NOW icon
21
ServiceNow
NOW
$98.4B
$130M 0.83%
855,585
-79,355
-8% -$12M
AMAT icon
22
Applied Materials
AMAT
$440B
$129M 0.83%
625,985
+234,092
+60% +$42.9M
DHR icon
23
Danaher
DHR
$127B
$128M 0.82%
513,522
-114,792
-18% -$28M
AVGO icon
24
Broadcom
AVGO
$1.89T
$122M 0.78%
919,820
-3,040
-0.3% -$377K
MU icon
25
Micron Technology
MU
$1.08T
$118M 0.76%
1,003,697
+456,174
+83% +$41.3M

Similar funds

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.